Organ SupportOVAGEN
10MG
$70
Description
Ovagen is a bioregulatory tripeptide (Glu-Asp-Leu) developed through the research of Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. It belongs to a class of short peptides known as cytogens or bioregulators, which are designed to interact with specific gene sequences to regulate protein synthesis in targeted organ systems. Ovagen specifically targets liver and gastrointestinal tract tissue, promoting cellular repair, regeneration, and normalized function. It works at the epigenetic level by influencing gene expression related to hepatic and digestive tissue maintenance.
Potential Benefits
Research Notes
Ovagen was developed as part of the Khavinson peptide bioregulation program at the Saint Petersburg Institute of Bioregulation and Gerontology, which has produced multiple organ-specific short peptides. Research published in the Bulletin of Experimental Biology and Medicine demonstrates that short bioregulatory peptides like Ovagen can interact with DNA and influence gene expression in a tissue-specific manner. Studies show improvements in hepatic function markers and GI tissue regeneration in preclinical models.
Usage Information
For research and educational purposes only. Consult with a qualified professional before use.
All peptides must be refrigerated upon receipt.
RESEARCH PURPOSES ONLY
This product is intended for research and educational purposes only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.